{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:59:28Z","timestamp":1792450768895,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["99014584"],"award-info":[{"award-number":["99014584"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["1771"],"award-info":[{"award-number":["1771"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"DOI":"10.1186\/s13099-025-00728-x","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T17:45:58Z","timestamp":1752774358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparative study of liver injury protection by Akkermansia muciniphila and Faecalibacterium prausnitzii interventions in live and cell-free supernatant forms via targeting the hepcidin \u2013 ferroportin axis in mice with CCl\u2084-induced liver fibrosis"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8679-1277","authenticated-orcid":false,"given":"Sara","family":"Ahmadi Badi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hananeh","family":"Tavakoli Aval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Amirhesam","family":"Seyedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Davari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Bereimipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soghra","family":"Khani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohreh","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Davar","family":"Siadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"issue":"1","key":"728_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12185-017-2365-3","volume":"107","author":"H Kawabata","year":"2018","unstructured":"Kawabata H. The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis. Int J Hematol. 2018;107(1):31\u201343.","journal-title":"Int J Hematol"},{"issue":"1","key":"728_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s10020-018-0008-7","volume":"24","author":"D Vela","year":"2018","unstructured":"Vela D. Low Hepcidin in liver fibrosis and cirrhosis; a Tale of progressive disorder and a case for a new biochemical marker. Mol Med. 2018;24(1):5.","journal-title":"Mol Med"},{"issue":"4","key":"728_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4254\/wjh.v8.i4.211","volume":"8","author":"S Lu","year":"2016","unstructured":"Lu S, Bennett RG, Kharbanda KK, Harrison-Findik DD. Lack of Hepcidin expression attenuates steatosis and causes fibrosis in the liver. World J Hepatol. 2016;8(4):211.","journal-title":"World J Hepatol"},{"issue":"7","key":"728_CR4","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1091\/mbc.e07-01-0060","volume":"18","author":"I De Domenico","year":"2007","unstructured":"De Domenico I, Ward DM, Langelier C, Vaughn MB, Nemeth E, Sundquist WI, et al. The molecular mechanism of hepcidin-mediated Ferroportin down-regulation. Mol Biol Cell. 2007;18(7):2569\u201378.","journal-title":"Mol Biol Cell"},{"issue":"4","key":"728_CR5","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/j.2040-4603.2013.tb00529.x","volume":"3","author":"JE Puche","year":"2013","unstructured":"Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3(4):1473\u201392.","journal-title":"Compr Physiol"},{"key":"728_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/bs.vh.2019.01.002","volume":"110","author":"YZ Ginzburg","year":"2019","unstructured":"Ginzburg YZ. Hepcidin-ferroportin axis in health and disease. Vitam Horm. 2019;110:17\u201345.","journal-title":"Vitam Horm"},{"key":"728_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/bs.vh.2019.01.005","volume":"110","author":"M-P Roth","year":"2019","unstructured":"Roth M-P, Meynard D, Coppin H. Regulators of Hepcidin expression. Vitam Horm. 2019;110:101\u201329.","journal-title":"Vitam Horm"},{"issue":"5","key":"728_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep4.1717","volume":"5","author":"KV Kowdley","year":"2021","unstructured":"Kowdley KV, Gochanour EM, Sundaram V, Shah RA, Handa P. Hepcidin signaling in health and disease: ironing out the details. Hepatol Commun. 2021;5(5):723\u201335.","journal-title":"Hepatol Commun"},{"issue":"1","key":"728_CR9","doi-asserted-by":"publisher","first-page":"13817","DOI":"10.1038\/ncomms13817","volume":"7","author":"CY Han","year":"2016","unstructured":"Han CY, Koo JH, Kim SH, Gardenghi S, Rivella S, Strnad P, et al. Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt. Nat Commun. 2016;7(1):13817.","journal-title":"Nat Commun"},{"key":"728_CR10","doi-asserted-by":"crossref","unstructured":"Nguyen HH, Swain MG. Avenues within the gut-liver-brain axis linking chronic liver disease and symptoms. Front NeuroSci. 2023;17.","DOI":"10.3389\/fnins.2023.1171253"},{"issue":"2","key":"728_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/med.21631","volume":"40","author":"ZM Qian","year":"2020","unstructured":"Qian ZM, Ke Y. Hepcidin and its therapeutic potential in neurodegenerative disorders. Med Res Rev. 2020;40(2):633\u201353.","journal-title":"Med Res Rev"},{"issue":"1","key":"728_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-018-1399-5","volume":"16","author":"D Vela","year":"2018","unstructured":"Vela D. Hepcidin, an emerging and important player in brain iron homeostasis. J Translational Med. 2018;16(1):1\u201318.","journal-title":"J Translational Med"},{"issue":"3","key":"728_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, De Gottardi A, Rescigno M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol. 2020;72(3):558\u201377.","journal-title":"J Hepatol"},{"issue":"4","key":"728_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","volume":"16","author":"JS Bajaj","year":"2019","unstructured":"Bajaj JS. Alcohol, liver disease and the gut microbiota. Nat Reviews Gastroenterol Hepatol. 2019;16(4):235\u201346.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"4","key":"728_CR15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/hep4.1331","volume":"3","author":"N Ohtani","year":"2019","unstructured":"Ohtani N, Kawada N. Role of the gut\u2013liver axis in liver inflammation, fibrosis, and cancer: a special focus on the gut microbiota relationship. Hepatol Commun. 2019;3(4):456\u201370.","journal-title":"Hepatol Commun"},{"key":"728_CR16","doi-asserted-by":"crossref","unstructured":"Delzenne NM, Knudsen C, Beaumont M, Rodriguez J, Neyrinck AM, Bindels LB. Contribution of the gut microbiota to the regulation of host metabolism and energy balance: A focus on the gut\u2013liver axis. Proceedings of the Nutrition Society. 2019;78(3):319\u2013\u200928.","DOI":"10.1017\/S0029665118002756"},{"issue":"1","key":"728_CR17","first-page":"6666114","volume":"2021","author":"X He","year":"2021","unstructured":"He X, Zhao S, Li Y. Faecalibacterium prausnitzii: A Next-Generation probiotic in gut disease improvement. Can J Infect Dis Med Microbiol. 2021;2021(1):6666114.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"4","key":"728_CR18","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.3390\/ijms24043900","volume":"24","author":"H Jian","year":"2023","unstructured":"Jian H, Liu Y, Wang X, Dong X, Zou X. Akkermansia muciniphila as a next-generation probiotic in modulating human metabolic homeostasis and disease progression: a role mediated by gut\u2013liver\u2013brain axes? Int J Mol Sci. 2023;24(4):3900.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"728_CR19","doi-asserted-by":"publisher","first-page":"e01596","DOI":"10.1128\/spectrum.01596-21","volume":"10","author":"J Xia","year":"2022","unstructured":"Xia J, Lv L, Liu B, Wang S, Zhang S, Wu Z, et al. Akkermansia muciniphila ameliorates acetaminophen-induced liver injury by regulating gut microbial composition and metabolism. Microbiol Spectr. 2022;10(1):e01596\u201321.","journal-title":"Microbiol Spectr"},{"issue":"2","key":"728_CR20","doi-asserted-by":"publisher","first-page":"e00484","DOI":"10.1128\/Spectrum.00484-21","volume":"9","author":"S Keshavarz Azizi Raftar","year":"2021","unstructured":"Keshavarz Azizi Raftar S, Ashrafian F, Yadegar A, Lari A, Moradi HR, Shahriary A, et al. The protective effects of live and pasteurized Akkermansia muciniphila and its extracellular vesicles against HFD\/CCl4-induced liver injury. Microbiol Spectr. 2021;9(2):e00484\u201321.","journal-title":"Microbiol Spectr"},{"key":"728_CR21","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.3389\/fmicb.2017.01804","volume":"8","author":"W Wu","year":"2017","unstructured":"Wu W, Lv L, Shi D, Ye J, Fang D, Guo F, et al. Protective effect of Akkermansia muciniphila against immune-mediated liver injury in a mouse model. Front Microbiol. 2017;8:1804.","journal-title":"Front Microbiol"},{"key":"728_CR22","doi-asserted-by":"publisher","first-page":"106348","DOI":"10.1016\/j.phrs.2022.106348","volume":"182","author":"C Rodriguez-Diaz","year":"2022","unstructured":"Rodriguez-Diaz C, Taminiau B, Garc\u00eda-Garc\u00eda A, Cueto A, Robles-D\u00edaz M, Ortega-Alonso A, et al. Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury. Pharmacol Res. 2022;182:106348.","journal-title":"Pharmacol Res"},{"issue":"14","key":"728_CR23","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.3390\/nu14142945","volume":"14","author":"W Hu","year":"2022","unstructured":"Hu W, Gao W, Liu Z, Fang Z, Wang H, Zhao J, et al. Specific strains of faecalibacterium prausnitzii ameliorate nonalcoholic fatty liver disease in mice in association with gut microbiota regulation. Nutrients. 2022;14(14):2945.","journal-title":"Nutrients"},{"key":"728_CR24","doi-asserted-by":"publisher","first-page":"1123547","DOI":"10.3389\/fmicb.2023.1123547","volume":"14","author":"J-H Shin","year":"2023","unstructured":"Shin J-H, Lee Y, Song E-J, Lee D, Jang S-Y, Byeon HR, et al. Faecalibacterium prausnitzii prevents hepatic damage in a mouse model of NASH induced by a high-fructose high-fat diet. Front Microbiol. 2023;14:1123547.","journal-title":"Front Microbiol"},{"issue":"5","key":"728_CR25","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","volume":"67","author":"C Grander","year":"2018","unstructured":"Grander C, Adolph TE, Wieser V, Lowe P, Wrzosek L, Gyongyosi B, et al. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut. 2018;67(5):891\u2013901.","journal-title":"Gut"},{"issue":"7516","key":"728_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","volume":"513","author":"N Qin","year":"2014","unstructured":"Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, et al. Alterations of the human gut Microbiome in liver cirrhosis. Nature. 2014;513(7516):59\u201364.","journal-title":"Nature"},{"issue":"4","key":"728_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/ph11040098","volume":"11","author":"B Yilmaz","year":"2018","unstructured":"Yilmaz B, Li H. Gut microbiota and iron: the crucial actors in health and disease. Pharmaceuticals. 2018;11(4):98.","journal-title":"Pharmaceuticals"},{"issue":"16","key":"728_CR28","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3390\/ani12162063","volume":"12","author":"Q Xiong","year":"2022","unstructured":"Xiong Q, Zhao J, Tian C, Ma W, Miao L, Liang L, et al. Regulation of a high-iron diet on lipid metabolism and gut microbiota in mice. Animals. 2022;12(16):2063.","journal-title":"Animals"},{"key":"728_CR29","unstructured":"Badi SA, Bereimipour A, Rohani P, Khatami S, Siadat SD. Interplay between gut microbiota and the master iron regulator, hepcidin, in the pathogenesis of liver fibrosis. Pathogens Disease. 2024:ftae005."},{"issue":"7","key":"728_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00203-024-04007-2","volume":"206","author":"S Ahmadi Badi","year":"2024","unstructured":"Ahmadi Badi S, Malek A, Seyedi SA, Bereimipour A, Irian S, Shojaie S, et al. Direct and macrophage stimulation mediated effects of active, inactive, and cell-free supernatant forms of Akkermansia muciniphila and Faecalibacterium Duncaniae on Hepcidin gene expression in HepG2 cells. Arch Microbiol. 2024;206(7):1\u201314.","journal-title":"Arch Microbiol"},{"issue":"1","key":"728_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gut.2004.042127","volume":"54","author":"L Xu","year":"2005","unstructured":"Xu L, Hui A, Albanis E, Arthur M, O\u2019byrne S, Blaner W, et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut. 2005;54(1):142\u201351.","journal-title":"Gut"},{"issue":"9","key":"728_CR32","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.cmet.2022.07.009","volume":"34","author":"Y Xi","year":"2022","unstructured":"Xi Y, LaCanna R, Ma H-Y, N\u2019Diaye E-N, Gierke S, Caplazi P, et al. A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis. Cell Metabol. 2022;34(9):1377\u201393. e8.","journal-title":"Cell Metabol"},{"key":"728_CR33","unstructured":"Nguyen Q. Hands-on application development with pycharm: accelerate your Python applications using practical coding techniques in PyCharm. Packt Publishing Ltd; 2019."},{"key":"728_CR34","doi-asserted-by":"publisher","first-page":"105798","DOI":"10.1016\/j.micpath.2022.105798","volume":"173","author":"SA Badi","year":"2022","unstructured":"Badi SA, Malek A, Paolini A, Masoumi MR, Seyedi SA, Amanzadeh A, et al. Downregulation of ACE, AGTR1, and ACE2 genes mediating SARS-CoV-2 pathogenesis by gut microbiota members and their postbiotics on Caco-2 cells. Microb Pathog. 2022;173:105798.","journal-title":"Microb Pathog"},{"issue":"4","key":"728_CR35","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1007\/s11033-021-07097-z","volume":"49","author":"E Shakerian","year":"2022","unstructured":"Shakerian E, Afarin R, Akbari R, Mohammadtaghvaei N. Effect of Quercetin on the fructose-activated human hepatic stellate cells, LX-2, an in-vitro study. Mol Biol Rep. 2022;49(4):2839\u201345.","journal-title":"Mol Biol Rep"},{"key":"728_CR36","doi-asserted-by":"crossref","unstructured":"Shakerian E, Akbari R, Mohammadtaghvaei N, Gahrooie MM, Afarin R. Quercetin reduces hepatic fibrogenesis by inhibiting TGF-\u03b2\/Smad3 signaling pathway in LX-2 cell line. Jundishapur J Nat Pharm Prod. 2022;17(1).","DOI":"10.5812\/jjnpp.113484"},{"issue":"5","key":"728_CR37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3748\/wjg.v25.i5.521","volume":"25","author":"KJ Mehta","year":"2019","unstructured":"Mehta KJ, Farnaud SJ, Sharp PA. Iron and liver fibrosis: mechanistic and clinical aspects. World J Gastroenterol. 2019;25(5):521.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"728_CR38","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/labinvest.2012.52","volume":"92","author":"N Naz","year":"2012","unstructured":"Naz N, Malik IA, Sheikh N, Ahmad S, Khan S, Blaschke M, et al. Ferroportin-1 is a \u2018nuclear\u2019-negative acute-phase protein in rat liver: a comparison with other iron-transport proteins. Lab Invest. 2012;92(6):842\u201356.","journal-title":"Lab Invest"},{"key":"728_CR39","doi-asserted-by":"crossref","unstructured":"D\u2019anna MC, Giorgi G, Roque ME. Immunohistochemical studies on duodenum, spleen and liver in mice: distribution of Ferroportin and prohepcidin in an inflammation model. 2011.","DOI":"10.4067\/S0717-95022011000300014"},{"issue":"6","key":"728_CR40","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3(6):1101\u20138.","journal-title":"Nat Protoc"},{"issue":"D1","key":"728_CR41","doi-asserted-by":"publisher","first-page":"D777","DOI":"10.1093\/nar\/gkab1019","volume":"50","author":"D Dai","year":"2022","unstructured":"Dai D, Zhu J, Sun C, Li M, Liu J, Wu S, et al. GMrepo v2: a curated human gut Microbiome database with special focus on disease markers and cross-dataset comparison. Nucleic Acids Res. 2022;50(D1):D777\u201384.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"728_CR42","first-page":"2368","volume":"48","author":"Y-J Zhou","year":"2023","unstructured":"Zhou Y-J, Liu J-M, Liu B, Wang Z-X, Fan X-Y, Huang P-Z, et al. Significance of high expression of C5orf46 in gastric cancer and potential intervention of tarditional Chinese medicine based on bioinformatics, molecular docking, and cell experiments. Zhongguo Zhong Yao Za zhi\u2009=\u2009zhongguo Zhongyao zazhi\u2009=\u2009china. J Chin Materia Med. 2023;48(9):2368\u201378.","journal-title":"J Chin Materia Med"},{"issue":"7","key":"728_CR43","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.ajpath.2021.04.005","volume":"191","author":"SA Bloomer","year":"2021","unstructured":"Bloomer SA, Brown KE. Hepcidin and iron metabolism in experimental liver injury. Am J Pathol. 2021;191(7):1165\u201379.","journal-title":"Am J Pathol"},{"issue":"1","key":"728_CR44","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1038\/s41598-022-06414-1","volume":"12","author":"SKA Raftar","year":"2022","unstructured":"Raftar SKA, Ashrafian F, Abdollahiyan S, Yadegar A, Moradi HR, Masoumi M, et al. The anti-inflammatory effects of Akkermansia muciniphila and its derivates in HFD\/CCL4-induced murine model of liver injury. Sci Rep. 2022;12(1):2453.","journal-title":"Sci Rep"},{"issue":"7","key":"728_CR45","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1038\/ismej.2017.24","volume":"11","author":"E Munukka","year":"2017","unstructured":"Munukka E, Rintala A, Toivonen R, Nylund M, Yang B, Takanen A, et al. Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice. ISME J. 2017;11(7):1667\u201379.","journal-title":"ISME J"},{"issue":"52","key":"728_CR46","doi-asserted-by":"publisher","first-page":"677","DOI":"10.4103\/pm.pm_584_16","volume":"13","author":"D Li","year":"2017","unstructured":"Li D, Zheng J, Hu Y, Hou H, Hao S, Liu N, et al. Amelioration of intestinal barrier dysfunction by Berberine in the treatment of nonalcoholic fatty liver disease in rats. Pharmacognosy Magazine. 2017;13(52):677.","journal-title":"Pharmacognosy Magazine"},{"issue":"3","key":"728_CR47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Reviews Gastroenterol Hepatol. 2021;18(3):151\u201366.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"3","key":"728_CR48","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jhep.2014.04.034","volume":"61","author":"M Lunova","year":"2014","unstructured":"Lunova M, Goehring C, Kuscuoglu D, Mueller K, Chen Y, Walther P, et al. Hepcidin knockout mice fed with iron-rich diet develop chronic liver injury and liver fibrosis due to lysosomal iron overload. J Hepatol. 2014;61(3):633\u201341.","journal-title":"J Hepatol"},{"issue":"6","key":"728_CR49","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/hep.21895","volume":"46","author":"DD Harrison-Findik","year":"2007","unstructured":"Harrison-Findik DD, Klein E, Crist C, Evans J, Timchenko N, Gollan J. Iron\u2010mediated regulation of liver Hepcidin expression in rats and mice is abolished by alcohol. Hepatology. 2007;46(6):1979\u201385.","journal-title":"Hepatology"},{"issue":"4","key":"728_CR50","doi-asserted-by":"publisher","first-page":"577","DOI":"10.14218\/JCTH.2021.00289","volume":"10","author":"H Chen","year":"2022","unstructured":"Chen H, Zhao W, Yan X, Huang T, Yang A. Overexpression of Hepcidin alleviates steatohepatitis and fibrosis in a diet-induced nonalcoholic steatohepatitis. J Clin Translational Hepatol. 2022;10(4):577.","journal-title":"J Clin Translational Hepatol"},{"issue":"3","key":"728_CR51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5223\/pghn.2021.24.3.295","volume":"24","author":"N Tsutsumi","year":"2021","unstructured":"Tsutsumi N, Nishimata S, Shimura M, Kashiwagi Y, Kawashima H. Hepcidin levels and pathological characteristics in children with fatty liver disease. Pediatr Gastroenterol Hepatol Nutr. 2021;24(3):295.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"issue":"12","key":"728_CR52","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.1038\/emm.2017.207","volume":"49","author":"Y-S Lee","year":"2017","unstructured":"Lee Y-S, Kim Y-H, Jung YS, Kim K-S, Kim D-K, Na S-Y, et al. Hepatocyte toll-like receptor 4 mediates lipopolysaccharide-induced Hepcidin expression. Exp Mol Med. 2017;49(12):e408\u2013e.","journal-title":"Exp Mol Med"},{"key":"728_CR53","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00109-008-0313-7","volume":"86","author":"MV Verga Falzacappa","year":"2008","unstructured":"Verga Falzacappa MV, Casanovas G, Hentze MW, Muckenthaler MU. A bone morphogenetic protein (BMP)-responsive element in the Hepcidin promoter controls HFE2-mediated hepatic Hepcidin expression and its response to IL-6 in cultured cells. J Mol Med. 2008;86:531\u201340.","journal-title":"J Mol Med"},{"issue":"1","key":"728_CR54","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1053\/j.gastro.2006.10.018","volume":"132","author":"A Pietrangelo","year":"2007","unstructured":"Pietrangelo A, Dierssen U, Valli L, Garuti C, Rump A, Corradini E, et al. STAT3 is required for IL-6-gp130\u2013dependent activation of Hepcidin in vivo. Gastroenterology. 2007;132(1):294\u2013300.","journal-title":"Gastroenterology"},{"issue":"7","key":"728_CR55","doi-asserted-by":"publisher","first-page":"e03004","DOI":"10.1128\/AEM.03004-19","volume":"86","author":"S Kim","year":"2020","unstructured":"Kim S, Lee Y, Kim Y, Seo Y, Lee H, Ha J, et al. Akkermansia muciniphila prevents fatty liver disease, decreases serum triglycerides, and maintains gut homeostasis. Appl Environ Microbiol. 2020;86(7):e03004\u201319.","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"728_CR56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/livers1030014","volume":"1","author":"E Kalo","year":"2021","unstructured":"Kalo E, Read S, Ahlenstiel G. Targeting gut\u2013liver axis for treatment of liver fibrosis and portal hypertension. Livers. 2021;1(3):147\u201379.","journal-title":"Livers"},{"key":"728_CR57","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1007\/s00253-020-10633-9","volume":"104","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Chen L, Zhao Y, Wang C, Duan C, Yang G, et al. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation. Appl Microbiol Biotechnol. 2020;104:5273\u201382.","journal-title":"Appl Microbiol Biotechnol"},{"key":"728_CR58","doi-asserted-by":"crossref","unstructured":"An L, Wirth U, Koch D, Schirren M, Drefs M, Koliogiannis D et al. The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases. J Gastrointest Surg. 2022:1\u201313.","DOI":"10.1007\/s11605-021-05188-7"},{"issue":"8","key":"728_CR59","first-page":"1092","volume":"91","author":"I De Domenico","year":"2006","unstructured":"De Domenico I, Ward DM, Nemeth E, Ganz T, Corradini E, Ferrara F, et al. Molecular and clinical correlates in iron overload associated with mutations in Ferroportin. Haematologica. 2006;91(8):1092.","journal-title":"Haematologica"},{"issue":"3","key":"728_CR60","doi-asserted-by":"publisher","first-page":"129829","DOI":"10.1016\/j.bbagen.2020.129829","volume":"1865","author":"C Link","year":"2021","unstructured":"Link C, Knopf JD, Marques O, Lemberg MK, Muckenthaler MU. The role of cellular iron deficiency in controlling iron export. Biochim Et Biophys Acta (BBA)-General Subj. 2021;1865(3):129829.","journal-title":"Biochim Et Biophys Acta (BBA)-General Subj"},{"issue":"3","key":"728_CR61","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tibs.2015.11.012","volume":"41","author":"AR Bogdan","year":"2016","unstructured":"Bogdan AR, Miyazawa M, Hashimoto K, Tsuji Y. Regulators of iron homeostasis: new players in metabolism, cell death, and disease. Trends Biochem Sci. 2016;41(3):274\u201386.","journal-title":"Trends Biochem Sci"},{"key":"728_CR62","doi-asserted-by":"publisher","first-page":"105205","DOI":"10.1016\/j.jff.2022.105205","volume":"96","author":"K Skrypnik","year":"2022","unstructured":"Skrypnik K, Olejnik-Schmidt A, Miko\u0142ajczyk-Stecyna J, Schmidt M, Suliburska J. Influence of supplementation of probiotic bacteria Lactobacillus plantarum and Lactobacillus curvatus on selected parameters of liver iron metabolism in rats on high-fat iron-deficient diet. J Funct Foods. 2022;96:105205.","journal-title":"J Funct Foods"},{"issue":"7","key":"728_CR63","first-page":"1347","volume":"1852","author":"B Silva","year":"2015","unstructured":"Silva B, Faustino P. An overview of molecular basis of iron metabolism regulation and the associated pathologies. Biochim Et Biophys Acta (BBA)-Molecular Basis Disease. 2015;1852(7):1347\u201359.","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Basis Disease"},{"issue":"1","key":"728_CR64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1574-6941.2012.01461.x","volume":"83","author":"A Dostal","year":"2013","unstructured":"Dostal A, Fehlbaum S, Chassard C, Zimmermann MB, Lacroix C. Low iron availability in continuous in vitro colonic fermentations induces strong dysbiosis of the child gut microbial consortium and a decrease in main metabolites. FEMS Microbiol Ecol. 2013;83(1):161\u201375.","journal-title":"FEMS Microbiol Ecol"},{"issue":"1","key":"728_CR65","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cmet.2019.10.005","volume":"31","author":"NK Das","year":"2020","unstructured":"Das NK, Schwartz AJ, Barthel G, Inohara N, Liu Q, Sankar A, et al. Microbial metabolite signaling is required for systemic iron homeostasis. Cell Metabol. 2020;31(1):115\u201330. e6.","journal-title":"Cell Metabol"},{"issue":"1","key":"728_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2202-6-3","volume":"6","author":"P Aguirre","year":"2005","unstructured":"Aguirre P, Mena N, Tapia V, Arredondo M, N\u00fa\u00f1ez MT. Iron homeostasis in neuronal cells: a role for IREG1. BMC Neurosci. 2005;6(1):1\u201311.","journal-title":"BMC Neurosci"},{"issue":"8","key":"728_CR67","first-page":"1326","volume":"1832","author":"I Pelizzoni","year":"2013","unstructured":"Pelizzoni I, Zacchetti D, Campanella A, Grohovaz F, Codazzi F. Iron uptake in quiescent and inflammation-activated astrocytes: a potentially neuroprotective control of iron burden. Biochim Et Biophys Acta (BBA)-Molecular Basis Disease. 2013;1832(8):1326\u201333.","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Basis Disease"},{"issue":"41","key":"728_CR68","doi-asserted-by":"publisher","first-page":"16334","DOI":"10.1523\/JNEUROSCI.0708-13.2013","volume":"33","author":"JC Lieblein-Boff","year":"2013","unstructured":"Lieblein-Boff JC, McKim DB, Shea DT, Wei P, Deng Z, Sawicki C, et al. Neonatal E. coli infection causes neuro-behavioral deficits associated with hypomyelination and neuronal sequestration of iron. J Neurosci. 2013;33(41):16334\u201345.","journal-title":"J Neurosci"},{"issue":"4","key":"728_CR69","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/diseases7040058","volume":"7","author":"H Fukui","year":"2019","unstructured":"Fukui H. Role of gut dysbiosis in liver diseases: what have we learned so far? Diseases. 2019;7(4):58.","journal-title":"Diseases"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00728-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-025-00728-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00728-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:11:30Z","timestamp":1757254290000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-025-00728-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["728"],"URL":"https:\/\/doi.org\/10.1186\/s13099-025-00728-x","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Animal Experiment Committee Pasteur Institute of Iran (IR.PII.REC.1399.029).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}